These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Overview of ifosfamide in small cell and non-small cell lung cancer. Johnson DH Semin Oncol; 1990 Apr; 17(2 Suppl 4):24-30. PubMed ID: 2159187 [TBL] [Abstract][Full Text] [Related]
47. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verwey J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R Eur J Cancer Clin Oncol; 1987 Mar; 23(3):311-21. PubMed ID: 3595691 [TBL] [Abstract][Full Text] [Related]
48. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)]. Teufel G; Pfleiderer A Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795 [TBL] [Abstract][Full Text] [Related]
49. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC Cochrane Database Syst Rev; 2012 Dec; 12():CD006300. PubMed ID: 23235629 [TBL] [Abstract][Full Text] [Related]
50. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC Cochrane Database Syst Rev; 2010 Feb; (2):CD006300. PubMed ID: 20166081 [TBL] [Abstract][Full Text] [Related]
51. Ifosfamide: an old drug recently rediscovered. Cavalli F Eur J Cancer Clin Oncol; 1988 Jun; 24(6):959-61. PubMed ID: 3409945 [No Abstract] [Full Text] [Related]
52. Preclinical phase II study of ifosfamide in human tumour xenografts in vivo. Berger DP; Fiebig HH; Winterhalter BR; Wallbrecher E; Henss H Cancer Chemother Pharmacol; 1990; 26 Suppl():S7-11. PubMed ID: 2347054 [TBL] [Abstract][Full Text] [Related]
53. The anticancer spectrum of ifosfamide. Hunter HL; Harrison EF Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868 [No Abstract] [Full Text] [Related]
54. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006300. PubMed ID: 26421585 [TBL] [Abstract][Full Text] [Related]
55. [Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report]. Kehl A; Bergholz M; von Heyden HW; Nagel GA Onkologie; 1983 Apr; 6(2):84-6. PubMed ID: 6306532 [No Abstract] [Full Text] [Related]
56. Ifosfamide/mesa and encephalopathy. Cantwell BM; Harris AL Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016 [No Abstract] [Full Text] [Related]
57. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial. Gandola L; Pozzi E; Tansini G G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387 [No Abstract] [Full Text] [Related]